Infrared thermography to assess proliferation and involution of infantile hemangiomas: A prospective cohort study

JAMA Dermatology

Volumn 150, Issue 9, 2014, Pages 964-969

  Mohammed, Javed Ayoub ^a   Balma Mena, Alexandra ^b   Chakkittakandiyil, Ajith ^c   Matea, Florentina ^d   Pope, Elena ^e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b National Children's Hospital   (Costa Rica)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NADOLOL; PROPRANOLOL; TIMOLOL MALEATE;

ARTICLE; CAPILLARY HEMANGIOMA; CHILD SAFETY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INFRARED PHOTOGRAPHY; INTERMETHOD COMPARISON; MALE; NEWBORN; NEWBORN ASSESSMENT; NEWBORN MONITORING; NON INVASIVE MEASUREMENT; PROSPECTIVE STUDY; TEMPERATURE SENSITIVITY; TERTIARY CARE CENTER; TUMOR GROWTH; VISUAL ANALOG SCALE; CELL PROLIFERATION; DIAGNOSTIC USE; HEMANGIOMA; INFANT; INFRARED RADIATION; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SKIN TUMOR; THERMOGRAPHY;

CELL PROLIFERATION; COHORT STUDIES; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; INFRARED RAYS; MALE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; THERMOGRAPHY;

EID: 84908233207     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.112     Document Type: Article

References (26)

1. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? a systematic review of the medical literature. Pediatr Dermatol. 2008;25(2): 168-173.
2. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med. 1999;341(3):173-181.
3. Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5%or 0.1%gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol. 2012; 29(1):28-31.
4. Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics. 2007;119(6):e1239-e1247.
5. Ho NT, Lansang P, Pope E. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J AmAcad Dermatol. 2007; 56(1):63-68.
6. Bertrand J, McCuaig C, Dubois J, Hatami A, Ondrejchak S, Powell J. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Pediatr Dermatol. 2011;28(6):649-654.
7. TsangMW, Garzon MC, Frieden IJ. How to measure a growing hemangioma and assess response to therapy. Pediatr Dermatol. 2006;23(2): 187-190.
8. Dixon JJ, James D, Fleming PJ, Kennedy CT. A novelmethod for estimating the volume of capillary haemangioma to determine response to treatment. Clin Exp Dermatol. 1997;22(1):20-22.
9. Berk DR, Berk EJ, Bruckner AL. A novelmethod for calculating the volume of hemangiomas. Pediatr Dermatol. 2011;28(4):478-482.
10. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-2651.
11. Schiestl C, Neuhaus K, Zoller S, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr. 2011;170(4): 493-501.
12. Saxena AK, Willital GH. Infrared thermography: experience from a decade of pediatric imaging. Eur J Pediatr. 2008;167(7):757-764.
13. Lavery LA, Higgins KR, Lanctot DR, et al. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool. Diabetes Care. 2007;30 (1):14-20.
14. Armstrong DG, Holtz-Neiderer K,Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am J Med. 2007;120(12):1042-1046.
15. Miki Y. Thermographic evaluations of haemangiomas. Australas J Dermatol. 1975;16(3): 114-117.
16. Desmons F, Houdas Y, Deffrenne C, Lakiere C. Thermographic study of hemangiomas of children. Angiology. 1976;27(9):494-501.
17. Haggstrom AN, Beaumont JL, Lai JS, et al. Measuring the severity of infantile hemangiomas: instrument development and reliability. Arch Dermatol. 2012;148(2):197-202.
18. Talaat AA, ElbasiounyMS, Elgendy DS, Elwakil TF. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations. J Pediatr Surg. 2012;47(4):707-714.
19. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009;124(3):e423-e431.
20. Moukaddam H, Pollak J, Haims AH. MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol. 2009;38(6):535-547.
21. Wilmanska D, Antosik-Biernacka A, Przewratil P, SzubertW, Stefanczyk L, Majos A. The role of MRI in diagnostic algorithm of cervicofacial vascular anomalies in children. Pol J Radiol. 2013;78(2):7-14.
22. Bingham MM, Saltzman B, Vo NJ, Perkins JA. Propranolol reduces infantile hemangioma volume and vessel density. Otolaryngol Head Neck Surg. 2012;147(2):338-344.
23. Flors L, Leiva-Salinas C, Maged IM, et al. MR imaging of soft-tissue vascular malformations: diagnosis, classification, and therapy follow-up. Radiographics. 2011;31(5):1321-1341.
24. Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. Acta Paediatr. 2012;101(10):e469-e474.
25. Chang LC, Haggstrom AN, Drolet BA, et al; Hemangioma Investigator Group. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008;122 (2):360-367.
26. Garcia-RomeroMT, Chakkittakandiyil A, Pope E. The role of infrared thermography in evaluation of proliferative infantile hemangiomas: results of a pilot study. Int J Dermatol. 2014;53(3):e216-e217.